Carrie L. Bourdow

CIK 1638989 · Acting CEO · last filed 2024-10-10

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$7.1K

Companies

3

Total Filings

39

Lifetime Open-Market Net

$115.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TRVN President & CEO 642,923 $0.01 $7.1K $117.9K 26 2023-12-15
Nabriva Therapeutics plc (NBRV) Delisted Director 9,933 $1.42 $14.1K -$2.4K 8 2022-08-03
Carisma Therapeutics Inc. (SESN) Delisted Director 40,000 $12.58 $503.0K $0 4 2022-06-24

Recent Filings · Page 3 of 4

39 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-02-26 Carisma Therapeutics Inc. (SESN) Delisted Grant (A) $0 EDGAR
2019-12-13 TRVN Grant (A) +657,000 $0 EDGAR
2019-12-04 TRVN Tax (F) −17,804 -$12.3K EDGAR
2019-09-20 TRVN Grant (A) $0 EDGAR
2019-08-01 Nabriva Therapeutics plc (NBRV) Delisted Grant (A) $0 EDGAR
2019-06-04 TRVN Tax (F) −17,802 -$20.8K EDGAR
2019-02-05 TRVN Grant (A) +50,000 $51.0K EDGAR
2018-12-07 TRVN Grant (A) +250,000 $0 EDGAR
2018-10-01 TRVN Grant (A) $0 EDGAR
2018-05-04 Nabriva Therapeutics plc (NBRV) Delisted Grant (A) $0 EDGAR
Showing 2130 of 39
Page 3 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.